ProfileGDS4718 / 1558390_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 17% 18% 12% 17% 8% 12% 14% 17% 16% 14% 13% 7% 15% 13% 13% 13% 13% 16% 15% 14% 19% 15% 10% 12% 17% 18% 14% 10% 18% 13% 15% 16% 12% 15% 15% 14% 16% 20% 14% 15% 11% 14% 15% 15% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.0380817
GSM549102patient 115, normal, homogenized [OPG study]4.0697118
GSM549104patient 119, normal, homogenized [OPG study]3.8417512
GSM549108patient 138, normal, homogenized [OPG study]4.0721817
GSM549119patient 077, normal, homogenized [OPG study]3.708368
GSM549133patient 032, cancer, homogenized [OPG study]3.8149412
GSM549139patient 042, cancer, homogenized [OPG study]3.901214
GSM549099patient 107, normal, homogenized [OPG study]4.0638617
GSM549109patient 139, normal, homogenized [OPG study]4.0309516
GSM549110patient 046, normal, homogenized [OPG study]3.9155714
GSM549114patient 063, normal, homogenized [OPG study]3.8595313
GSM549122patient 082, normal, homogenized [OPG study]3.656297
GSM549134patient 033, cancer, homogenized [OPG study]3.9702415
GSM549136patient 036, cancer, homogenized [OPG study]3.8548113
GSM549140patient 044, cancer, homogenized [OPG study]3.8429213
GSM549111patient 047, normal, homogenized [OPG study]3.8686813
GSM549113patient 057, normal, homogenized [OPG study]3.8410213
GSM549132patient 031, cancer, homogenized [OPG study]3.9693816
GSM549137patient 038, cancer, homogenized [OPG study]3.966715
GSM549142patient 047, cancer, homogenized [OPG study]4.0153414
GSM549100patient 110, normal, homogenized [OPG study]4.1298619
GSM549107patient 135, normal, homogenized [OPG study]3.9286115
GSM549115patient 068, normal, homogenized [OPG study]3.7488310
GSM549116patient 072, normal, homogenized [OPG study]3.841212
GSM549120patient 078, normal, homogenized [OPG study]4.0204217
GSM549131patient 030, cancer, homogenized [OPG study]4.0410818
GSM549118patient 074, normal, homogenized [OPG study]3.9234514
GSM549129patient 027, cancer, homogenized [OPG study]3.7951710
GSM549123patient 088, normal, homogenized [OPG study]4.079118
GSM549124patient 006, cancer, homogenized [OPG study]3.9355613
GSM549126patient 015, cancer, homogenized [OPG study]3.9445315
GSM549128patient 025, cancer, homogenized [OPG study]3.9606816
GSM549103patient 117, normal, homogenized [OPG study]3.8906312
GSM549117patient 073, normal, homogenized [OPG study]3.9561215
GSM549138patient 041, cancer, homogenized [OPG study]3.9602215
GSM549141patient 045, cancer, homogenized [OPG study]3.8640214
GSM549130patient 028, cancer, homogenized [OPG study]4.0140316
GSM549101patient 111, normal, homogenized [OPG study]4.1603320
GSM549105patient 128, normal, homogenized [OPG study]3.9189814
GSM549106patient 134, normal, homogenized [OPG study]3.9292915
GSM549112patient 048, normal, homogenized [OPG study]3.8113811
GSM549125patient 011, cancer, homogenized [OPG study]3.9369814
GSM549127patient 024, cancer, homogenized [OPG study]3.9332715
GSM549135patient 035, cancer, homogenized [OPG study]3.9282915